Operating Lease, Right-of-Use Asset of CROSS COUNTRY HEALTHCARE INC from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CROSS COUNTRY HEALTHCARE INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • CROSS COUNTRY HEALTHCARE INC Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $2,206,000, a 11% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

CROSS COUNTRY HEALTHCARE INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,206,000 -$262,000 -11% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 $1,851,000 -$849,000 -31% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $2,003,000 -$632,000 -24% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $2,219,000 +$388,000 +21% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $2,468,000 -$131,000 -5% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 $2,700,000 +$72,000 +2.7% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $2,635,000 +$329,000 +14% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $1,831,000 -$675,000 -27% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $2,599,000 -$655,000 -20% 31 Dec 2023 10-K 05 Mar 2025 2024 FY
Q3 2023 $2,628,000 -$621,000 -19% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $2,306,000 -$2,752,000 -54% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $2,506,000 -$2,941,000 -54% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $3,254,000 -$4,234,000 -57% 31 Dec 2022 10-K 05 Mar 2025 2024 FY
Q3 2022 $3,249,000 -$4,815,000 -60% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $5,058,000 -$3,567,000 -41% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $5,447,000 -$4,388,000 -45% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $7,488,000 -$2,959,000 -28% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 $8,064,000 -$2,462,000 -23% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $8,625,000 -$2,928,000 -25% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $9,835,000 -$6,428,000 -40% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $10,447,000 -$6,517,000 -38% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $10,526,000 -$7,270,000 -41% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $11,553,000 -$8,701,000 -43% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $16,263,000 -$4,702,000 -22% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $16,964,000 +$16,964,000 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $17,796,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $20,254,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $20,965,000 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 05 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.